June 6th 2023
Carolyn H. Goldschmidt, DO, a neurologist at NorthShore University Health System in Chicago, talked about a retrospective study analyzing disease-modifying therapies in multiple sclerosis patients at CMSC 2023.
Addressing Healthcare Inequities in Stroke Care: How Can We Play an Active Role in Improving Outcomes for All Patients?
Applying Precision Medicine: Improving Care for Patients with Motor Complications of Parkinson Disease
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
BURST CME™: Taking ALS Management to the Next Level
FAQs in MS: Exploring Provocative Questions From MS Meeting Updates
Taking Pompe Disease Management to the Next Level: Optimizing Clinical Assessments and Treatment Decision-Making
From Clinical Trials to Clinical Practice – Incorporating Screening and Assessment Strategies for the Early Diagnosis of Alzheimer Disease
Post-COVID Abnormal Sleep is Common, With Potential Impacts on CognitionJune 4th 2023
Among patients with post-acute sequelae from COVID-19 infection, self-reported cognitive symptoms were correlated with severity of fatigue, anxiety, and depression, but not subjective sleep disturbance.
Solriamfetol Improves Cognition in Patients With Obstructive Sleep ApneaJune 4th 2023
In a study of 59 individuals with obstructive sleep apnea, solriamfetol yielded cognitive improvements at post-dose time points throughout the day, along with improvements in Patient Global Impression of Severity.
NeurologyLive® Brain Games: June 4, 2023June 4th 2023
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is the history of the American Academy of Sleep Medicine.
Leading by Example: How the University of Rochester’s Neuropalliative Care Service Expands Treatment PossibilitiesJune 2nd 2023
With few neuropalliative care services available in the US, the University of Rochester stands as a prime example of how a successful program can transform patient care.
Burnout Among Healthcare Providers Affects Worker Quality of Life and Reduces Quality of Patient CareJune 2nd 2023
Many programs and activities at the 2023 CMSC Annual Meeting focused on burnout prevention and supporting the current and future MS care workforce.
Certain Factors May Assist in Predicting Clinical Phenotype Following Optic NeuritisJune 2nd 2023
Factors such as older age, poor steroid responsiveness, and plasma exchange were associated with NMOSD phenotype, while normal or thinned retinal nerve fiber layer and short-segment hyperintensity were associated with idiopathic optic neuritis.
Mindfulness-Based Stress Reduction Intervention Shows Potential to Treat Silent Symptoms of Multiple SclerosisJune 1st 2023
In mixed-effect analyses adjusting for multiple cofounders, changes in inflammatory gene expression correlated inversely with changes in patient-reported stress, loneliness, hair cortisol, and aspects of interoceptive awareness.
CMS Announces Plan to Provide Coverage of Antiamyloid Therapies for Alzheimer DiseaseJune 1st 2023
In July, the FDA is expected to make a decision on lecanemab (Leqembi), an antiamyloid therapy previously approved under the accelerated approval pathway, for a potential traditional approval for early-stage Alzheimer disease.